Rheumatology Therapeutics Market by Disease Type (Rheumatoid Arthritis, Osteoarthritis, Lupus, Gout, Ankylosing spondylitis and other), Drug Type (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics, Disease Modifying Anti-Rheumatic Drugs (DMARDs), Corticosteroids and Others), Distribution Channel (Retail Pharmacy, Online Pharmacy, Hospitals): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2022.: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2022

Global rheumatology therapeutics market is expected to reach USD 50.9 billion by 2022, growing at a CAGR of 2.9 % between 2016 and 2022.

15-Feb-2018 | Number of pages: 110 | Report Code: ZMR-2616 | Report Format : | Status : Published

Analysis

Rheumatic diseases are among the most prevalent chronic conditions around the world. About 0.5-1% world’s population is affected by arthritis. Rheumatic diseases include many types of arthritis and autoimmune diseases that affect the bones, joints and other components of the musculoskeletal system. These disease conditions are known as a disease of the aged but are frequently prevalent in both men and women younger than 60 years. The prevalence of arthritis is very high among adults with conditions, such as diabetes, heart disease, and obesity.  Arthritis and rheumatic conditions pose as one of the serious economic and health burden to society due to the high cost of treatment.

The rheumatology therapeutics market is expected to witness a robust growth in the coming years. Rising geriatric population, new drugs launch and growing R&D investments are key factors accelerating the growth of the market. However, high capital requirements in drug manufacturing, stringent FDA rules, and regulation for drug approvals are restraining the growth of the market. However, flourishing pharmaceutical industry in emerging Asia Pacific region and growing demand for technologically enhanced products such as biologics and biosimilars for the treatment of rheumatic diseases are expected to present lucrative opportunities to the key players.  

Rheumatology Therapeutics Market

On the basis of disease type, the global rheumatology therapeutics market is divided into rheumatoid arthritis, osteoarthritis, lupus, gout, ankylosing spondylitis and other. Rheumatoid arthritis had highest prevalence rate and accounted for the major share in global rheumatology therapeutics market in 2016.

On the basis of drug type the market is segmented into non-steroidal anti-inflammatory drugs, analgesics, disease modifying anti-rheumatic drugs, corticosteroids and other. In drug type, DMARDs segment dominated the market in 2016 owing to increase in use in the early stage of treatment of disease and growing adoption of biologics drugs for the treatment of moderate to severe rheumatoid arthritis and osteoarthritis. The distribution channel segment of rheumatology therapeutics includes a retail pharmacy, online pharmacy, and hospitals.

By geography, North America dominated the market owing to the increased prevalence of rheumatic diseases. Furthermore, the presence of superior healthcare facilities and faster adoption of biologics and biosimilars for treatment of moderate to severe rheumatoid arthritis is driving the growth of rheumatology therapeutics market in the region.

Europe was the second after North America in terms of revenue generation. Rising elderly population, the prevalence of sedentary lifestyle has increased the rate of rheumatic diseases in this region. In addition, advanced healthcare infrastructure, higher demand for quality products is anticipated to account market growth in the forecast period.

The Asia Pacific was fastest growing market. The rising incidence of rheumatic diseases in geriatric population is expected to boost the market in coming years. Latin America is emerging market and is expected to present moderate growth in the coming years owing to significant reforms in healthcare infrastructure. The Middle East and Africa are anticipated to witness significant growth within the forecast period.

Some of the key players operating in the rheumatology therapeutics market are AbbVie, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Amgen, Inc., Janssen Biotech, Inc., Novartis AG, Genentech, Inc., Takeda Pharmaceutical and Sanofi.


Related Reports

Patient Monitoring Devices Market by Product (Cardiac monitoring devices, Neuromonitoring devices, Respiratory monitoring devices, Anesthesia monitor, Hemodynamic monitoring devices, Fetal and neonatal monitoring, Multiparameter monitoring devices and Others), by Type (Wireless Sensor Technology, MHealth, Telehealth, Wearable Devices, and Others), and End use (Hospitals, Ambulatory surgical centers, Homecare settings, and Others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5368 | Report Format:

The report covers forecast and analysis for the Patient Monitoring Devices market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Patient Mon...Read More

COVID-19 Drug Delivery Devices Market by Product (Prefilled Syringes, Needle-Free Injectors, Inhalers, Patches, and Others), by Route of Administration (Parenteral, Nasal, and Dermal), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Aug-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5367 | Report Format:

The report covers forecast and analysis for the COVID-19 drug delivery devices market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the COVID-1...Read More

Face Shield Market by Material (Cellulose Acetate, Polycarbonate, and Others), and End-User (Oil & Gas, Construction, Healthcare, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Aug-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5366 | Report Format:

The report covers forecast and analysis for the face shield market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the face shield market along w...Read More

Medical Protective Goggles Market by Type (Reusable Protective Goggles and Disposable Protective Goggles), and End-User (Clinics, Hospitals, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Aug-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5365 | Report Format:

The report covers forecast and analysis for the medical protective goggles market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the medical pro...Read More

Request Free Brochure

COVID-19

A Global Pandemic

Request the coronavirus impact analysis across industries and market

Request impact analysis on this market
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.